ArticleThe Indian journal of radiology & imaging2026
Evaluation of Maternal Ophthalmic Artery Doppler Velocimetry at 18 to 24 Weeks of Gestational Age in the Prediction of Preeclampsia.
Article in The Indian journal of radiology & imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preeclampsia (PE) is a crucial health issue that complicates roughly 10% of gestations and causes more than 50,000 deaths yearly worldwide. Most women with PE have mildly high blood pressure, a small amount of excess protein in the urine, and they do not experience any symptoms of the disease. This is the reason that prenatal screening of increased blood pressure is done in later pregnancy period. Aims and Objectives: The aim of this study was to evaluate the role of maternal ophthalmic artery Doppler velocimetry in predicting PE. The objectives were to examine the velocimetry values in the women undergoing antenatal scan at 18 to 24 weeks of gestation and their potential value in the subsequent development of PE. Materials and Methods: A prospective observational study was conducted on 800 women who visited the hospital for antenatal ultrasound at 18 to 24 gestational weeks. Ophthalmic artery Doppler study was conducted to obtain the spectral waveform from both eyes after recording the patient history. Doppler indices like first peak systolic velocity (PSV1), second peak systolic velocity (PSV2), pulsatility index (PI), end-diastolic velocity (EDV), resistivity index (RI), systolic/diastolic ratio (S/D), and PSV2 to PSV1 ratio (PSV ratio: PSV2/PSV1) were obtained and their average values were obtained. All patients were then followed up till termination of pregnancy to document the development of PE. Statistical Analysis: The collected data were entered into the Microsoft Excel and then analyzed and statistically evaluated using SPSS-25 version. Results: The study revealed that a total 95 subjects developed PE (11.9%) from a total of 800 subjects. The ophthalmic artery PSV2/PSV1 ratio and PSV2 of right and left eye were significantly increased in patients with PE. The EDV in pre-eclamptic patients was also increased as compared to normotensive patients. The average values of the PI and RI were decreased in PE patients as compared to normotensive patients. The S/D ratio was also decreased in patients who later developed PE as compared to normotensive patients. Conclusion: Ophthalmic artery Doppler velocimetry can detect PE in early stages and is a cheap, noninvasive, readily available, safe, and reliable tool for evaluation of hemodynamic changes in normotensive pregnancy, and even more so in PE. The most reliable parameters being the PSV2 and PSV2/PSV1 ratio with sensitivity of both the parameters being more than 90%. The other parameters like increased EDV and decreased PI and RI also have some role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.